Literature DB >> 31267764

Hi-Plex2: a simple and robust approach to targeted sequencing-based genetic screening.

Fleur Hammet1,2, Khalid Mahmood3,2, Thomas R Green3, Tu Nguyen-Dumont1,4, Melissa C Southey1,4,5, Daniel D Buchanan3, Andrew Lonie2, Katherine L Nathanson6, Fergus J Couch7, Bernard J Pope3,2, Daniel J Park1,2.   

Abstract

We have previously reported Hi-Plex, a multiplex PCR methodology for building targeted DNA sequencing libraries that offers a low-cost protocol compatible with high-throughput processing. Here, we detail an improved protocol, Hi-Plex2, that more effectively enables the robust construction of small-to-medium panel-size libraries while maintaining low cost, simplicity and accuracy benefits of the Hi-Plex platform. Hi-Plex2 was applied to three panels, comprising 291, 740 and 1193 amplicons, targeting genes associated with risk for breast and/or colon cancer. We show substantial reduction of off-target amplification to enable library construction for small-to-medium-sized design panels not possible using the previous Hi-Plex chemistry.

Entities:  

Keywords:  Hi-Plex; genetic screening; multiplex PCR; targeted DNA sequencing; variant detection

Mesh:

Substances:

Year:  2019        PMID: 31267764     DOI: 10.2144/btn-2019-0026

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  2 in total

1.  Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing.

Authors:  Melissa C Southey; James G Dowty; Moeen Riaz; Jason A Steen; Anne-Laure Renault; Katherine Tucker; Judy Kirk; Paul James; Ingrid Winship; Nicholas Pachter; Nicola Poplawski; Scott Grist; Daniel J Park; Bernard J Pope; Khalid Mahmood; Fleur Hammet; Maryam Mahmoodi; Helen Tsimiklis; Derrick Theys; Amanda Rewse; Amanda Willis; April Morrow; Catherine Speechly; Rebecca Harris; Robert Sebra; Eric Schadt; Paul Lacaze; John J McNeil; Graham G Giles; Roger L Milne; John L Hopper; Tú Nguyen-Dumont
Journal:  NPJ Breast Cancer       Date:  2021-12-09

2.  Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer.

Authors:  Tú Nguyen-Dumont; James G Dowty; Robert J MacInnis; Jason A Steen; Moeen Riaz; Pierre-Antoine Dugué; Anne-Laure Renault; Fleur Hammet; Maryam Mahmoodi; Derrick Theys; Helen Tsimiklis; Gianluca Severi; Damien Bolton; Paul Lacaze; Robert Sebra; Eric Schadt; John McNeil; Graham G Giles; Roger L Milne; Melissa C Southey
Journal:  Cancers (Basel)       Date:  2021-03-24       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.